Intervention Review

Adjuvant progestagens for endometrial cancer

  1. Pierre PL Martin-Hirsch1,*,
  2. Andrew Bryant2,
  3. Sarah L Keep1,
  4. Henry C Kitchener3,
  5. Richard Lilford4

Editorial Group: Cochrane Gynaecological Cancer Group

Published Online: 15 JUN 2011

Assessed as up-to-date: 9 MAY 2011

DOI: 10.1002/14651858.CD001040.pub2

How to Cite

Martin-Hirsch PPL, Bryant A, Keep SL, Kitchener HC, Lilford R. Adjuvant progestagens for endometrial cancer. Cochrane Database of Systematic Reviews 2011, Issue 6. Art. No.: CD001040. DOI: 10.1002/14651858.CD001040.pub2.

Author Information

  1. 1

    Royal Preston Hospital, Lancashire Teaching Hospital NHS Trust, Gynaecological Oncology Unit, Preston, Lancashire, UK

  2. 2

    Newcastle University, Institute of Health and Society, Newcastle upon Tyne, UK

  3. 3

    St. Mary's Hospital, Academic Unit of Obstetrics and Gynaecology, University of Manchester, Manchester, UK

  4. 4

    University of Birmingham, Department of Public Health and Epidemiology, Birmingham, UK

*Pierre PL Martin-Hirsch, Gynaecological Oncology Unit, Royal Preston Hospital, Lancashire Teaching Hospital NHS Trust, Sharoe Green Lane, Fullwood, Preston, Lancashire, PR2 9HT, UK. pierre.martinhirsch@btinternet.com.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 15 JUN 2011

SEARCH

  1. Current Version

    Adjuvant progestagens for endometrial cancer

    Pierre PL Martin-Hirsch, Andrew Bryant, Sarah L Keep, Henry C Kitchener and Richard Lilford

    Article first published online: 15 JUN 2011 | DOI: 10.1002/14651858.CD001040.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Progestagens for endometrial cancer

    Pierre PL Martin-Hirsch, Gerry G Jarvis, Henry C Kitchener and Richard Lilford

    Article first published online: 21 JAN 2009 | DOI: 10.1002/14651858.CD001040